Cycle Pharmaceuticals Partners With US-Firm To Utilize 3D Printing Technology For Rare Disease Treatment Development
Source: Pixabay

Cycle Pharmaceuticals Partners With US-Firm To Utilize 3D Printing Technology For Rare Disease Treatment Development

Cycle Pharmaceuticals shook hands with US-based firm, Aprecia Pharmaceuticals as they agreed to develop and commercialize treatments for rare diseases using the advanced technology of 3D printing, recently reported Cambridge…

Continue Reading Cycle Pharmaceuticals Partners With US-Firm To Utilize 3D Printing Technology For Rare Disease Treatment Development
Bioprinted Liver Tissue Could Help Treat A1AD, And it Just Got Orphan Drug Status
Source: Pixabay

Bioprinted Liver Tissue Could Help Treat A1AD, And it Just Got Orphan Drug Status

Organovo Holdings recently stated that its 3D bioprinted therapeutic liver tissue was granted orphan drug status by the Food and Drug Administration (FDA). Taylor Crouch, the company CEO, was excited…

Continue Reading Bioprinted Liver Tissue Could Help Treat A1AD, And it Just Got Orphan Drug Status